Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019

SELL
$178.4 - $208.25 $659,366 - $769,692
-3,696 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $270,893 - $305,397
-1,462 Reduced 28.34%
3,696 $766,000
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $8,468 - $9,512
-51 Reduced 0.98%
5,158 $952,000
Q1 2018

Apr 30, 2018

BUY
$169.43 - $198.0 $4,066 - $4,752
24 Added 0.46%
5,209 $888,000
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $19,073 - $21,310
-113 Reduced 2.13%
5,185 $901,000
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $886,302 - $1.01 Million
5,298
5,298 $987,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Forward Management, LLC Portfolio

Follow Forward Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forward Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forward Management, LLC with notifications on news.